Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Zolgensma Market Report 2025

Zolgensma Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Spinal Muscular Atrophy (SMA) Type 1, Spinal Muscular Atrophy (SMA) Type 2, Spinal Muscular Atrophy (SMA) Type 3, Pre-symptomatic Spinal Muscular Atrophy (SMA)), By Age Group (Pediatric (Infants And Children), Adults), By Distribution Channel (Hospitals, Specialty Clinics, Pharmacies)

Zolgensma Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Zolgensma Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Zolgensma Market Definition

Zolgensma refers to a gene therapy developed to treat spinal muscular atrophy (SMA), a rare genetic disorder that leads to muscle weakness and motor function loss. It is used for replacing the defective or missing SMN1 gene in children under the age of two, helping to restore motor function and improve survival outcomes.

The main indications on the solgensma include spinal muscular atrophy (SMA) type 1, spinal muscular atrophy (SMA) type 2, spinal muscular atrophy (SMA) type 3, and pre-symptomatic spinal muscular atrophy (SMA). Spinal muscular atrophy (SMA) type 1 refers to the most severe form of SMA, a genetic disorder characterized by the rapid degeneration of motor neurons in the spinal cord, leading to progressive muscle weakness and atrophy. The various age groups include pediatric (infants and children) and adults and are distributed through several channels such as hospitals, specialty clinics, and pharmacies.

Zolgensma Market Segmentation

The zolgensma market covered in this report is segmented –

1) By Indication: Spinal Muscular Atrophy (SMA) Type 1; Spinal Muscular Atrophy (SMA) Type 2; Spinal Muscular Atrophy (SMA) Type 3; Pre-symptomatic Spinal Muscular Atrophy (SMA)

2) By Age Group: Pediatric (Infants And Children); Adults

3) By Distribution Channel: Hospitals; Specialty Clinics; Pharmacies

Zolgensma Market Size and growth rate 2025 to 2029: Graph

Zolgensma Market Size 2025 And Growth Rate

The zolgensma market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing prevalence of spinal muscular atrophy, rising awareness of genetic disorders, increasing healthcare expenditure, rising prevalence of genetic testing, and rising number of health insurance plans.

Zolgensma Market Growth Forecast

The zolgensma market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising interest in personalized medicine approaches, increasing global healthcare spending, growth in telemedicine, increasing focus on rare disease treatment, and growth in digital health technologies. Major trends in the forecast period include advancements in gene therapy technologies, technological advancements in manufacturing processes, development of new biomarkers, advancements in digital health technologies, and development of intrathecal formulations.

Book your 30 minutes free consultation with our research experts

Contact Us

Zolgensma Market Driver: Increasing Incidence of Spinal Muscular Atrophy Drives Demand for Gene Therapy Solutions

Increasing incidence of spinal muscular atrophy is expected to propel the growth of the zolgensma market going forward. Spinal muscular atrophy (SMA) is a genetic disorder characterized by the degeneration of motor neurons in the spinal cord, leading to progressive muscle weakness and atrophy, primarily affecting infants and young children, and potentially resulting in significant physical disabilities and life-threatening complications. The increasing incidence of spinal muscular atrophy (SMA) can be attributed to improved genetic testing and newborn screening programs, which facilitate earlier and more accurate diagnoses, leading to greater identification of cases that may have previously gone unrecognized. Zolgensma works by delivering a functional copy of the SMN1 gene to patients with spinal muscular atrophy (SMA), thereby addressing the underlying genetic cause of the disease and helping to restore the production of the survival motor neuron (SMN) protein, which is critical for motor function and muscle strength, ultimately improving motor skills and survival in affected infants and young children. For instance, in August 2023, according to the National Health Service England, a UK-based government agency, approximately 70 children are born with spinal muscular atrophy (SMA) each year in the United Kingdom. As of November 2022, 118 out of 161 patients with SMA Type 1 were over the age of two and living without the need for permanent ventilatory support. Therefore, the increasing incidence of spinal muscular atrophy is driving the growth of the zolgensma market.

Zolgensma Market Driver: Rising Prevalence of Rare Diseases Driving Demand for Advanced Gene Therapies

Rising prevalence of rare diseases is expected to propel the growth of the zolgensma market going forward. A rare disease is a medical condition that affects a small percentage of the population, often characterized by unique symptoms and challenges in diagnosis and treatment. The rising incidence of rare diseases can be attributed to improved diagnostic tools and greater awareness, which facilitate earlier detection and identification of conditions that may have previously gone unrecognized. Zolgensma treats patients with rare diseases like spinal muscular atrophy by delivering a functional copy of the defective SMN1 gene, enabling the production of the SMN protein critical for motor neuron survival and muscle function. For instance, in September 2024, according to the European Union, a Netherlands-based international organization, there are over 6,000 distinct rare diseases that collectively affect up to 36 million people across the European Union. Therefore, the rising prevalence of rare diseases is driving the growth of the zolgensma market.

Global Zolgensma Market Major Players

Major companies operating in the zolgensma market are Novartis AG

Global Zolgensma Market Trend: Strategic Investments Driving Growth And Expansion In The Zolgensma Market

The key trend in the zolgensma market is focusing on strategic investments to enhance production capacity, expand geographic reach, and accelerate research and development efforts for innovative gene therapy solutions. Strategic investments enhance production capacity to accommodate increasing demand, supporting research and development for advancements in gene therapy, enabling geographic expansion to reach more patients globally, improving supply chain efficiency, and fostering collaborations to enhance awareness and access to treatment. For instance, in April 2022, Novartis AG, a Switzerland-based pharmaceutical corporation, obtained commercial licensure approval from the United States Food and Drug Administration for its Durham, North Carolina facility, dedicated to multi-product gene therapy manufacturing. This approval enables the 170,000-square-foot facility to manufacture, test, and release commercial Zolgensma, as well as produce gene therapy products for ongoing and future clinical trials. Additionally, the facility will support the production of gene therapy products for both current and future clinical trials.

Regional Analysis For The Global Zolgensma Market

North America was the largest region in the zolgensma market in 2024. The regions covered in the zolgensma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the zolgensma market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Zolgensma Market?

The zolgensma market consists of infusion sets, syringes, and other medical supplies for intravenous administration. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Zolgensma Industry?

The zolgensma market research report is one of a series of new reports from The Business Research Company that provides zolgensma market statistics, including the zolgensma industry global market size, regional shares, competitors with the zolgensma market share, detailed zolgensma market segments, market trends, and opportunities, and any further data you may need to thrive in the zolgensma industry. This zolgensma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Zolgensma Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The zolgensma market covered in this report is segmented –
1) By Indication: Spinal Muscular Atrophy (SMA) Type 1; Spinal Muscular Atrophy (SMA) Type 2; Spinal Muscular Atrophy (SMA) Type 3; Pre-symptomatic Spinal Muscular Atrophy (SMA)
2) By Age Group: Pediatric (Infants And Children); Adults
3) By Distribution Channel: Hospitals; Specialty Clinics; Pharmacies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Novartis AG
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Zolgensma Market Characteristics

    3. Zolgensma Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Zolgensma Market Trends And Strategies

    5. Zolgensma Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Zolgensma Growth Analysis And Strategic Analysis Framework

    6.1. Global Zolgensma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Zolgensma Market Growth Rate Analysis

    6.4. Global Zolgensma Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Zolgensma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Zolgensma Total Addressable Market (TAM)

    7. Global Zolgensma Pricing Analysis & Forecasts

    8. Zolgensma Market Segmentation

    8.1. Global Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Spinal Muscular Atrophy (SMA) Type 1

    Spinal Muscular Atrophy (SMA) Type 2

    Spinal Muscular Atrophy (SMA) Type 3

    Pre-symptomatic Spinal Muscular Atrophy (SMA)

    8.2. Global Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Pediatric (Infants And Children)

    Adults

    8.3. Global Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Specialty Clinics

    Pharmacies

    9. Global Zolgensma Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Zolgensma Market Regional And Country Analysis

    10.1. Global Zolgensma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Zolgensma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Zolgensma Market

    11.1. Asia-Pacific Zolgensma Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Zolgensma Market

    12.1. China Zolgensma Market Overview

    12.2. China Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Zolgensma Market

    13.1. India Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Zolgensma Market

    14.1. Japan Zolgensma Market Overview

    14.2. Japan Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Zolgensma Market

    15.1. Australia Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Zolgensma Market

    16.1. South Korea Zolgensma Market Overview

    16.2. South Korea Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Zolgensma Market

    17.1. Western Europe Zolgensma Market Overview

    17.2. Western Europe Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Zolgensma Market

    18.1. UK Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Zolgensma Market

    19.1. Germany Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Zolgensma Market

    20.1. France Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Zolgensma Market

    21.1. Eastern Europe Zolgensma Market Overview

    21.2. Eastern Europe Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Zolgensma Market

    22.1. North America Zolgensma Market Overview

    22.2. North America Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Zolgensma Market

    23.1. USA Zolgensma Market Overview

    23.2. USA Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Zolgensma Market

    24.1. Canada Zolgensma Market Overview

    24.2. Canada Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Zolgensma Market

    25.1. South America Zolgensma Market Overview

    25.2. South America Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Zolgensma Market

    26.1. Middle East Zolgensma Market Overview

    26.2. Middle East Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Zolgensma Market

    27.1. Africa Zolgensma Market Overview

    27.2. Africa Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Zolgensma Market Competitive Landscape And Company Profiles

    28.1. Zolgensma Market Competitive Landscape

    28.2. Zolgensma Market Company Profiles

    28.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    29. Global Zolgensma Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Zolgensma Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Zolgensma Market

    32. Recent Developments In The Zolgensma Market

    33. Zolgensma Market High Potential Countries, Segments and Strategies

    33.1 Zolgensma Market In 2029 - Countries Offering Most New Opportunities

    33.2 Zolgensma Market In 2029 - Segments Offering Most New Opportunities

    33.3 Zolgensma Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Zolgensma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Zolgensma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Zolgensma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Zolgensma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Zolgensma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Zolgensma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Zolgensma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Novartis AG Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Gene Therapy Market 2023 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Cell And Gene Therapy Market 2021 - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell and Gene Therapy Global Market Report 2025 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell & Gene Therapy Manufacturing Services Global Market Report 2025 – By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases), By Application (Commercial Manufacturing, Clinical Manufacturing), By End-user (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DNA And Gene Chip Global Market Report 2025 – By Type( Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types), By Application( Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications), By End User( Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gene Expression Global Market Report 2025 – By Product (Kits And Reagents, DNA Chip Or Microarray, Other Products), By Process (Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation), By Technique (RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis), By Application (Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nucleic Acid Based Gene Therapy Market 2022 - By Nucleic Acid Technology (Anti-Sense and Anti-Gene Oligonucleotides, siRNA and RNA Interference, Gene Transfer Therapy, Ribozymes, Aptamers), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Zolgensma market?

Zolgensma refers to a gene therapy developed to treat spinal muscular atrophy (SMA), a rare genetic disorder that leads to muscle weakness and motor function loss. It is used for replacing the defective or missing SMN1 gene in children under the age of two, helping to restore motor function and improve survival outcomes. For further insights on the Zolgensma market, request a sample here

How will the Zolgensma market drivers and restraints affect the market dynamics? What forces will shape the Zolgensma industry going forward?

The Zolgensma market major growth driver - Increasing Incidence of Spinal Muscular Atrophy Drives Demand for Gene Therapy Solutions. For further insights on the Zolgensma market, request a sample here

What is the forecast market size or the forecast market value of the Zolgensma market?

The Zolgensma market size has grown strongly in recent years. The zolgensma market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing prevalence of spinal muscular atrophy, rising awareness of genetic disorders, increasing healthcare expenditure, rising prevalence of genetic testing, and rising number of health insurance plans. The zolgensma market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising interest in personalized medicine approaches, increasing global healthcare spending, growth in telemedicine, increasing focus on rare disease treatment, and growth in digital health technologies. Major trends in the forecast period include advancements in gene therapy technologies, technological advancements in manufacturing processes, development of new biomarkers, advancements in digital health technologies, and development of intrathecal formulations. For further insights on the Zolgensma market, request a sample here

How is the Zolgensma market segmented?

The zolgensma market covered in this report is segmented –
1) By Indication: Spinal Muscular Atrophy (SMA) Type 1; Spinal Muscular Atrophy (SMA) Type 2; Spinal Muscular Atrophy (SMA) Type 3; Pre-symptomatic Spinal Muscular Atrophy (SMA)
2) By Age Group: Pediatric (Infants And Children); Adults
3) By Distribution Channel: Hospitals; Specialty Clinics; Pharmacies For further insights on the Zolgensma market, request a sample here

Which region has the largest share of the Zolgensma market? What are the other regions covered in the report?

North America was the largest region in the zolgensma market in 2024. The regions covered in the zolgensma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Zolgensma market, request a sample here.

Who are the major players in the Zolgensma market?

Major companies operating in the zolgensma market are Novartis AG . For further insights on the Zolgensma market, request a sample here.

What are the key trends in the Zolgensma market?

Major trends in the Zolgensma market include Strategic Investments Driving Growth And Expansion In The Zolgensma Market. For further insights on the Zolgensma market, request a sample here.

What are the major opportunities in the Zolgensma market? What are the strategies for the Zolgensma market?

For detailed insights on the major opportunities and strategies in the Zolgensma market, request a sample here.

How does the Zolgensma market relate to the overall economy and other similar markets?

For detailed insights on Zolgensma's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Zolgensma industry?

For detailed insights on the mergers and acquisitions in the Zolgensma industry, request a sample here.

What are the key dynamics influencing the Zolgensma market growth? SWOT analysis of the Zolgensma market.

For detailed insights on the key dynamics influencing the Zolgensma market growth and SWOT analysis of the Zolgensma industry, request a sample here.